1. Home
  2. MUX vs GENB Comparison

MUX vs GENB Comparison

Compare MUX & GENB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo McEwen Mining Inc.

MUX

McEwen Mining Inc.

HOLD

Current Price

$24.11

Market Cap

1.6B

ML Signal

HOLD

GENB

Generate Biomedicines Inc. Common Stock

N/A

Current Price

$12.46

Market Cap

1.7B

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
MUX
GENB
Founded
1979
2018
Country
Canada
United States
Employees
1432
N/A
Industry
Precious Metals
Sector
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.7B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
MUX
GENB
Price
$24.11
$12.46
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
6
Target Price
$26.63
$23.20
AVG Volume (30 Days)
913.5K
315.8K
Earning Date
05-06-2026
05-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$37.86
N/A
Revenue Next Year
$31.10
$45.45
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.15
$11.00
52 Week High
$29.70
$14.21

Technical Indicators

Market Signals
Indicator
MUX
GENB
Relative Strength Index (RSI) 54.83 50.89
Support Level $22.96 $11.25
Resistance Level $24.88 $13.61
Average True Range (ATR) 1.18 0.88
MACD 0.50 0.01
Stochastic Oscillator 62.88 43.09

Price Performance

Historical Comparison
MUX
GENB

About MUX McEwen Mining Inc.

McEwen Inc, formerly McEwen Mining Inc is a mining and minerals production and exploration company that focuses on precious and base minerals in Argentina, Mexico, and the United States. The company generates its revenue from gold and silver production. It owns and operates the wholly-owned El Gallo 1 mine in Mexico and holds a minority stake in the company that manages the San Jose mine in Argentina. More than half of the company's gold output comes from the El Gallo 1 mine, while the remaining gold production and the majority of silver production are sourced from the San Jose mine. Geographically, majority of production occurs in the United States.

About GENB Generate Biomedicines Inc. Common Stock

Generate Biomedicines Inc is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. The company's single operating segment is engaged in the field of generative biology by using machine learning for drug discovery and development through the programming of novel protein therapeutics. Its product candidates include: GB-0895, GB-4362, and GB-5267. Through the company's Generate Platform, it can generate medicines on demand across multiple therapeutic modalities with unprecedented speed representing a fundamental shift in drug discovery.

Share on Social Networks: